AfroCentric Group Integrated Annual Report 2017
|
Performance summary for the year |
5 |
|
About this report |
6 |
|
CHAIRPERSON’S REPORT |
8 |
|
ORGANISATIONAL OVERVIEW |
13 |
|
Profile |
14 |
|
Investment case |
18 |
|
Company history |
20 |
|
Group structure |
22 |
|
Our footprint |
23 |
|
HOW WE CREATE VALUE |
25 |
|
Business model |
26 |
|
Materiality |
30 |
|
Stakeholder engagement |
40 |
|
Strategy |
46 |
|
GROUP CEO’S REPORT |
51 |
|
PERFORMANCE |
57 |
|
Group CFO’s report |
58 |
|
Results at a glance |
61 |
|
OPERATIONAL REVIEWS |
65 |
|
Medscheme South Africa |
66 |
|
Pharmacy Direct, Curasana and Activo Health |
70 |
|
Aid for Aids |
73 |
|
AfroCentric Health Solutions |
75 |
|
Allegra |
77 |
|
Klinikka |
80 |
|
Wellness Odyssey |
82 |
|
Helios IT Solutions |
83 |
|
GOVERNANCE |
87 |
|
Board of Directors |
88 |
|
Corporate governance report |
92 |
|
Board committees and attendance |
96 |
|
Remuneration Committee report |
100 |
|
Our social impact |
108 |
|
SHAREHOLDER INFORMATION |
119 |
|
Financial calendar |
120 |
|
Notice of Annual General Meeting |
121 |
|
Annexure A – Salient features of the AfroCentric Group Long-Term Incentive Plan |
132 |
|
Glossary |
138 |
|
Form of proxy |
139 |
|
Appendix – Extract from section 58 of the Companies Act |
141 |
|
Administration and contact information |
143 |